SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

LPCN.O (LPCN.O) News

Follow LPCN.O (LPCN.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol LPCN.O Asset market Sector Markets 90 days 1 Updated Oct 07, 2026, 12:21 PM UTC Open live news feed
M Lipocine announces Health Canada approval of Tlando for testosterone replacement therapy Lipocine said Health Canada approved its Tlando for testosterone replacement therapy. EQUITY | Oct 07, 2026, 12:21 PM UTC